⌘K

Login Start Free

Home/Filings/4/0001077183-25-000122

4//SEC Filing

Perez David Brian 4

Accession 0001077183-25-000122

CIK 0001077183other

View on SEC.gov Company Profile

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 4:06 PM ET

Size

15.2 KB

Accession

0001077183-25-000122

Insider Transaction Report

Form 4

Period: 2025-06-01

NEOGENOMICS INCNEO

Perez David Brian

Director

Transactions

Exercise/Conversion
Common Stock
2025-06-01+12,254→ 33,890 total
Award
Restricted Stock Unit
2025-06-01+23,077→ 23,077 total
Exercise: $0.00From: 2026-06-01→ Common Stock (23,077 underlying)
Exercise/Conversion
Restricted Stock Unit
2025-06-01−12,254→ 0 total
Exercise: $0.00From: 2025-06-01→ Common Stock (12,254 underlying)
Award
Stock Option (Right to Buy)
2025-06-01+16,107→ 16,107 total
Exercise: $7.28From: 2026-06-01Exp: 2035-06-01→ Common Stock (16,107 underlying)

Holdings

Common Stock
(indirect: By Trust)
10,000
Stock Option (Right to Buy)
Exercise: $14.82From: 2024-08-10Exp: 2033-08-10→ Common Stock (8,353 underlying)
8,353
Stock Option (Right to Buy)
Exercise: $7.34From: 2023-06-10Exp: 2029-06-10→ Common Stock (9,730 underlying)
9,730
Stock Option (Right to Buy)
Exercise: $13.71From: 2025-06-01Exp: 2034-06-01→ Common Stock (8,672 underlying)
8,672

Footnotes (2)

[F1]Reflects release of restricted stock units that were previously reported on a Form 4.
[F2]Once vested, the shares of common stock are not subject to expiration.

Documents

1 file

4
wk-form4_1748981182.xmlPrimary
FORM 4

Issuer

NEOGENOMICS INC

CIK 0001077183

Entity typeother

Related Parties

1

filerCIK 0001765355

Filing Metadata

Form type: 4
Filed: Jun 2, 8:00 PM ET
Accepted: Jun 3, 4:06 PM ET
Size: 15.2 KB

View on SEC.gov